【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market summary
Chapter 3 Osteoporosis Drugs Market Variables, Trends & Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.2 Penetration & Growth Prospect Mapping
3.3 Osteoporosis Drugs – SWOT Analysis
3.4 Industry Analysis – Porter’s
3.5 Product Pipeline Analysis
3.6 Company Market Share, 2015
Chapter 4 Osteoporosis Drugs Product Estimates & Trend Analysis
4.1 Osteoporosis Drugs Market: Product Movement Analysis
4.2 Branded
4.2.1 Branded market, 2014 – 2025 (USD Million)
4.2.2 Bisphosphonates
4.2.2.1 Bisphosphonates market, 2014 – 2025 (USD Million)
4.2.3 Parathyroid Hormone Therapy
4.2.3.1 Parathyroid hormone therapy market, 2014 – 2025 (USD Million)
4.2.4 Calcitonin
4.2.4.1 Calcitonin market, 2014 – 2025 (USD Million)
4.2.5 Selective Estrogen Inhibitors Modulator (SERM)
4.2.5.1 SERM market, 2014 – 2025 (USD Million)
4.2.6 Rank Ligand Inhibitors
4.2.6.1 Rank ligand Inhibitors market, 2014 – 2025 (USD Million)
4.2.7 Others
4.2.7.1 Others market, 2014 – 2025 (USD Million)
4.3 Generic
4.3.1 Generic market, 2014 – 2025 (USD Million)
Chapter 5 Osteoporosis Drugs Regional Estimates & Trend Analysis, by Product
5.1 Osteoporosis drugs market share by region, 2015 & 2025
5.2 North America
5.2.1 North America osteoporosis drugs market, 2014 – 2025 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. osteoporosis drugs market, 2014 – 2025 (USD Million)
5.2.3 Canada
5.2.3.1 Canada osteoporosis drugs market, 2014 – 2025 (USD Million)
5.3 Europe
5.3.1 Europe osteoporosis drugs market, 2014 – 2025 (USD Million)
5.3.2 UK
5.3.2.1 UK osteoporosis drugs market, 2014 – 2025 (USD Million)
5.3.3 Germany
5.3.3.1 Germany osteoporosis drugs market, 2014 – 2025 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific osteoporosis drugs market, 2014 – 2025 (USD Million)
5.4.2 Japan
5.4.2.1 Japan osteoporosis drugs market, 2014 – 2025 (USD Million)
5.4.3 China
5.4.3.1 China osteoporosis drugs market, 2014 – 2025 (USD Million)
5.4.4 India
5.4.4.1 India osteoporosis drugs market, 2014 – 2025 (USD Million)
5.5 Latin America
5.5.1 Latin America osteoporosis drugs market, 2014 – 2025 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil osteoporosis drugs market, 2014 – 2025 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico osteoporosis drugs market, 2014 – 2025 (USD Million)
5.6 MEA
5.6.1 MEA osteoporosis drugs market, 2014 – 2025 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa osteoporosis drugs market, 2014 – 2025 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 Company Profiles
6.3.1 Pfizer, Inc.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Geographic Foothold
6.3.1.4 Product benchmarking
6.3.1.5 Strategic initiatives
6.3.2 F.Hoffmann La Roche
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Geographic Foothold
6.3.2.4 Product benchmarking
6.3.2.5 Strategic initiatives
6.3.3 Teva Pharmaceuticals
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Geographic Foothold
6.3.3.4 Product benchmarking
6.3.4 Novartis AG
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Geographic Foothold
6.3.4.4 Product benchmarking
6.3.4.5 Strategic initiatives
6.3.5 Merck & Co AG
6.3.5.1 Company overview
6.3.5.2 Financial Performance
6.3.5.3 Geographic Foothold
6.3.5.4 Product benchmarking
6.3.5.5 Strategic initiatives
6.3.6 Amgen, Inc.
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Geographic Foothold
6.3.6.4 Product benchmarking
6.3.6.5 Strategic initiatives
6.3.7 Allergan plc
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Geographic Foothold
6.3.7.4 Product benchmarking
6.3.7.5 Strategic initiatives
6.3.8 GlaxoSmithKline
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Geographic Foothold
6.3.8.4 Product benchmarking
6.3.8.5 Strategic initiatives
6.3.9 Eli Lilly and Company
6.3.9.1 Company overview
6.3.9.2 Financial performance
6.3.9.3 Geographic Foothold
6.3.9.4 Product Benchmarking
6.3.9.5 Strategic initiatives
【レポート販売概要】
■ タイトル：骨粗鬆症薬と保持器具の世界市場分析：製品別（ブランド、ビスホスホネート、副甲状腺ホルモン療法、カルシトニン、選択的エストロゲン阻害モジュレーター（SERM）、ランクリガンド阻害剤、ジェネリック）、セグメント予測、2014-2025■ 英文：Osteoporosis Drugs Market Analysis By Product (Branded, Bisphosphonates, Parathyroid Hormone Therapy, Calcitonin, Selective Estrogen Inhibitors Modulator (SERM), Rank Ligand Inhibitors, Generics), And Segment Forecasts, 2014-2025
■ 発行日：2017年1月31日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707629
■ 調査対象地域：グローバル
- 消費者直結型遺伝子検査の世界市場2015-2019About Genetic Testing Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is used as a medical tool to determine the genetic defects associated with a particular disease. Genetic testing is also used in non-clinical applications such as paternity testing and forensics. In cli …
- オフロード高性能車両の世界市場2016-2020About Off-Road Vehicles An off-road vehicle is equipped with systems and functions for driving on and off the pavement or road surface. Large tires mostly characterize the vehicle with wide treads and adjustable suspension. Most off-roader vehicles feature higher ground clearance, enhanced suspension system, and wide profile tires, which provide better traction and low-end torque to drive through …
- 世界の軍事用電子光学/赤外線（EO/IR）市場（2014-2024）Product Synopsis This report is the result of SDI's extensive market and company research covering the global military EO/IR Systems industry. It provides detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of the leading companies in the industry, and key news. Introduction and Landscape Why wa …
- 代用乳の世界市場予測（～2022年）The milk replacers market is projected to grow at a CAGR of 7.59% from 2017 to 2022, to reach a projected value of USD 3.54 Billion by 2022. The milk replacers market is driven by the rise in milk prices, increase in awareness of cost-benefits and nutritional aspects of milk replacer products, adoption of precision nutrition techniques, concerns regarding mortality and health-related aspects, and …
- Southern Union Company：石油・ガスバリューチェーン分析レポート2013Southern Union Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Southern Union Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Southern Union Company”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- Rectal Cancer：グローバル臨床試験レビューH2, 2013Rectal Cancer Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2013" provides data on the Rectal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rectal Cancer. It includes an overview of the trial numbers and their recruitment status as per the …
- Anadarko Petroleum Corporation：石油・ガスバリューチェーン分析レポート2013Anadarko Petroleum Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Anadarko Petroleum Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Anadarko Petroleum Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across th …
- 血管ステントの世界市場予測（～2021年）：ベアメタルステント、生体吸収性ステント、薬剤溶出ステントThe vascular stent market is projected to reach USD 17.68 billion by 2021 from USD 12.21 billion in 2016, at a CAGR of 7.7% from 2016 to 2021. The growth of this market is majorly driven by factors such as technological advancements in vascular stents, increasing number of angioplasty procedures, rising burden of vascular diseases, increasing demand for minimally invasive procedures, and rising ge …
- 実験室用ガス発生器の世界市場予測（～2024年）“Rising safety concerns related to the use of conventional gas cylinders, growing importance of analytical techniques in drug and food approval processes, and increasing R&D spending in target industries are the key factors driving the laboratory gas generators market.”The laboratory gas generators market is projected to reach USD 508 million by 2024 from USD 279 million in 2019, at a CAGR of 12.7 …
- 癌診断用の画像装置：グローバル市場分析と予測MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundatio …
- 2014年戦略提言：ドイツの病院腫瘍マーカー検査市場This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. …
- 拡張現実（AR）用ソフトウェアの世界市場予測（～2022年）“Increasing use of AR software in consumer electronics is the major driver for the augmented reality software market”The augmented reality software market was valued at USD 2.13 billion in 2016 and is expected to reach USD 35.22 billion by 2022, growing at a CAGR of 57.36% during the forecast period. The increasing demand for AR-based software applications for 3D visualization in the medical secto …
- 携帯型ワイヤレス医療機器の世界市場：モニタリング機器、治療機器、診断機器、ウェアラブル医療機器The wireless portable medical device market is expected to grow at a rapid pace due to growing income levels, and increasing prevalence of chronic and lifestyle disorders such as diabetes, respiratory, blood and cardiovascular diseases. A growing population coupled with high income levels and awareness about wellness and fitness are some of the factors driving the market growth. Further, integrati …
- 飲料用フレーバーシステムの世界市場予測（～2023年）“The beverage flavoring systems market is projected to grow at a CAGR of 6.1%.” The global beverage flavoring systems market was valued at USD 3.8 billion in 2018 and is projected to reach USD 5.2 billion by 2023, at a CAGR of 6.1% from 2018 to 2023. The market is driven by factors such as the increasing popularity of innovative flavors in soft drinks, the favorable regulatory environment for fort …
- エポキシ樹脂の世界市場分析：用途別（塗料・コーティング、風力タービン、複合材料、建設、電気・電子、接着剤）、セグメント予測The global epoxy resin market is expected to reach USD 14.26 billion by 2024, according to a new report by Grand View Research, Inc. The market is anticipated to be driven by end-use industries including automotive, aerospace, transportation, composites, decorative coatings, construction, industrial & marine coatings, electrical & electronics, especially in Asia Pacific. Epoxy resins are the most …
